Skip to content

Clinical trials

Anxiety Disorders trials in Switzerland with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Not applicable Country / region: Switzerland Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20092
20101
20132
20141
20151
20161
20184
20192
20208
20213
20222
20232
20244
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting10
Unknown status9
Terminated3
Not yet recruiting2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich9
University Hospital, Geneva6
University Hospital, Basel, Switzerland4
Ente Ospedaliero Cantonale, Bellinzona2
Insel Gruppe AG, University Hospital Bern2
University of Bern2
University of Lausanne Hospitals2
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland1
Centre Hospitalier Universitaire Vaudois1
Chantal Martin Soelch1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders46
Stress Disorders, Post-Traumatic6
Pain5
Mental Disorders3
Breast Neoplasms2
Depressive Disorder2
Neoplasms2
Postoperative Pain2
Sleep Initiation and Maintenance Disorders2
Sleep Wake Disorders2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.